Risk of gastrointestinal events with newly approved (after 2011) vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: a meta-analysis of randomized controlled trials
Crossref DOI link: https://doi.org/10.1007/s00228-017-2299-y
Published Online: 2017-07-15
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Jing
Gu, Jian
Funding for this research was provided by:
Fundamental Research Funds for the Central Universities, Southwest University for Nationalities (2017NZYQN29)
License valid from 2017-07-15